Michael Risk
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
- Urological Disorders and Treatments
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Treatment and Research 12
- Prostate Cancer Diagnosis and Treatment 8
- Renal cell carcinoma treatment 5
- Surgery 22
- Bladder and Urothelial Cancer Treatments 11
- Urinary and Genital Oncology Studies 8
- Co-authors
- Peter S. Nelson (6 shared papers)Ilsa M. Coleman (4 shared papers)Lawrence D. True (3 shared papers)Olga Klezovitch (1 shared paper)Philipp Dahm (13 shared papers)Jared M. Lucas (1 shared paper)Valeri Vasioukhin (1 shared paper)Lillian J. Eichner (1 shared paper)
- Journals
- Cochrane Database of Systematic Reviews (10 papers)The Journal of Urology (6 papers)Endocrinology (2 papers)Expert Review of Anticancer Therapy (2 papers)Urology (2 papers)
- Partner nations
- United StatesSouth KoreaGermany
In The Last Decade
Michael Risk
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Urology 143
- Pulmonary and Respiratory Medicine 471
- Cancer Research 145
- Molecular Biology 445
- Oncology 166
Countries citing papers authored by Michael Risk
This map shows the geographic impact of Michael Risk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Risk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Risk more than expected).
Fields of papers citing papers by Michael Risk
This network shows the impact of papers produced by Michael Risk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Risk. The network helps show where Michael Risk may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Risk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 222 | |
| 2 | 2008 | 209 | |
| 3 | 1996 | 87 | |
| 4 | 2009 | 58 | |
| 5 | 2016 | 55 | |
| 6 | 2010 | 43 | |
| 7 | 1998 | 39 | |
| 8 | 2017 | 37 | |
| 9 | 2013 | 34 | |
| 10 | 2019 | 34 | |
| 11 | 2015 | 24 | |
| 12 | The role of immunotherapy in prostate cancer: an overview of current approaches in development. | 2009 | 21 |
| 13 | 2018 | 21 | |
| 14 | 2018 | 20 | |
| 15 | 2018 | 16 | |
| 16 | 2019 | 15 | |
| 17 | Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Review | 2016 | 14 |
| 18 | 2005 | 14 | |
| 19 | 2009 | 13 | |
| 20 | Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay. | 2018 | 12 |
About Michael Risk
Michael Risk is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Urology and Oncology, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Molecular Biology Techniques and Applications (5 papers), Urological Disorders and Treatments (5 papers), Renal cell carcinoma treatment (5 papers) and Hormonal and reproductive studies (4 papers). The work is most often cited by research in Urology (143 citations), Pulmonary and Respiratory Medicine (471 citations), Cancer Research (145 citations), Molecular Biology (445 citations) and Oncology (166 citations). Michael Risk has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Peter S. Nelson, Ilsa M. Coleman, Lawrence D. True, Olga Klezovitch, Philipp Dahm, Jared M. Lucas, Valeri Vasioukhin, Lillian J. Eichner, Alvin Y. Liu and David Campbell. Their work appears in journals such as Cochrane Database of Systematic Reviews, The Journal of Urology, Endocrinology, Expert Review of Anticancer Therapy and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.